Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Nonvalvular Atrial Fibrillation – in-Group Comparison. Prospect. Pharm. Sci. 2022, 20 (1), 26-31. https://doi.org/10.56782/pps.36.